A surgeon explains the difference between semaglutide and tirzepatide
A short Facebook clip from a doctor walks through how the two popular weight loss drugs compare.
Recap by typeshit. Post by Facebook on Facebook.
See it on Facebook
More peptides
-
Fiscal.ai shares a chart saying Eli Lilly leads Novo in weight loss drugs Fiscal.ai shares a chart saying Eli Lilly leads Novo in weight loss drugs
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
-
Bon Appétit's Sam Stone tries a 'GLP-1 booster' smoothie powder for a week Bon Appétit's Sam Stone tries a 'GLP-1 booster' smoothie powder for a week
Sam Stone mixed GLP-1 Daily Support powder into a smoothie daily and came away with stomach aches and doubts about what it does.
-
Singapore approves Wegovy for MASH with liver fibrosis, a first there 
Singapore approves Wegovy for MASH with liver fibrosis, a first there
Dr Desmond Wai shares the Novo Nordisk news and notes the FDA cleared semaglutide for fatty liver disease in the US more than a year earlier.
-
Mama Cookie shares a weight loss journey update while on tirzepatide Mama Cookie shares a weight loss journey update while on tirzepatide
A short personal check-in from a creator who tags her post with tirzepatide. No numbers or details beyond the update itself.
-
Polskie Radio looks at whether Ozempic pills still work for weight loss Polskie Radio looks at whether Ozempic pills still work for weight loss
A search result from Polskie Radio on oral semaglutide and weight loss, with no details given beyond the question itself.
-
Dr David Barzilai on new studies asking if weight loss drugs slow biological aging peptides typeshitResearchDr David Barzilai on new studies asking if weight loss drugs slow biological aging
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
